InvestorsHub Logo
Followers 74
Posts 9169
Boards Moderated 0
Alias Born 04/25/2002

Re: None

Wednesday, 01/05/2022 9:19:42 AM

Wednesday, January 05, 2022 9:19:42 AM

Post# of 1125
I am a bit puzzled though as to WHY today's PR doesn't make any mention of how well Zyesami performed as compared to Remdesivir. Unless I'm missing something, those facts were left out. Isn't that what the FDA was asking for? It only references Zyesami as compared to a "placebo".



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NRXP News